| 【Company Research】CSPC Pharmaceutical (1093 HK) – Inline 1Q results amid COVID-19 outbreak |
| 【公司研究】滔搏 (6110 HK) – 7月起业务将重回正轨 |
| 【Company Research】Meituan Dianping (3690 HK) – Faster recovery ahead with expanding TAM |
| 【Company Research】Alibaba (BABA US) – Better-than-expected ecommerce recovery |
| 【Company Research】Pinduoduo (PDD US) – More bullish on topline growth |
| 【Company Research】Tongcheng-Elong (780 HK) – Moving to 2H20E recovery |
| 【Company Research】JOYY Inc. (YY US) – More bullish on Bigo’s overseas expansion |
| 【Company Research】Mengniu (2319 HK) – Sales recovery ahead of expectation |
| 【Sector Research】China Healthcare Sector – The race for a COVID-19 vaccine |
| 【Company Research】Xiaomi (1810 HK) – Strong 5G outlook and share gain; U/G to BUY |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
